Business Wire
Upcoming FDA Catalyst Set To Transform Q BioMed
Thursday, 17 January 2019 00:00
A low float stock Q BioMed (OTCMKTS: QBIO) may be the next thinly traded stock to jump as traders are anticipating an FDA decsion which will allow the emerging biotech to commercialize and generate revenues for the first time. The CEO of the company aknowledged in an interview this week, that the important news may come at any time.
Read more...
 
The Global Shape Memory Alloy Market (2018-2022); ATI, Furukawa Electric, Johnson Matthey, Nippon Seisen, and SAES Group are Dominating - ResearchAndMarkets.com
Friday, 11 January 2019 06:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Metals and Minerals
Read more...
 
The Global Shape Memory Alloy Market (2018-2022); ATI, Furukawa Electric, Johnson Matthey, Nippon Seisen, and SAES Group are Dominating - ResearchAndMarkets.com
Friday, 11 January 2019 06:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Metals and Minerals
Read more...
 
Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen® Wound Conforming Gel Matrix with Three Dosage Options
Friday, 11 January 2019 03:06
Read more...
 
Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen® Wound Conforming Gel Matrix with Three Dosage Options
Friday, 11 January 2019 03:06
Read more...
 
Cigna Corporation’s Fourth Quarter 2018 Earnings Release Details
Friday, 11 January 2019 03:06
Read more...
 
Cigna Corporation’s Fourth Quarter 2018 Earnings Release Details
Friday, 11 January 2019 03:06
Read more...
 
AbelsonTaylor Launches ICONS.HEALTH™, a Content Channel Exploring Innovation at the Intersection of Healthcare and Technology
Friday, 11 January 2019 03:06
Innovators and Entrepreneurs from Health-Tech Startups to Global Corporations Provide Insights in Casual Conversations about Serious Topics
Read more...
 
AbelsonTaylor Launches ICONS.HEALTH™, a Content Channel Exploring Innovation at the Intersection of Healthcare and Technology
Friday, 11 January 2019 03:06
Innovators and Entrepreneurs from Health-Tech Startups to Global Corporations Provide Insights in Casual Conversations about Serious Topics
Read more...
 
Puma Biotechnology and Knight Therapeutics Enter into Exclusive License Agreement to Commercialize NERLYNX® (neratinib) in Canada
Friday, 11 January 2019 02:06
David Schull or Alex Fudukidis, Russo Partners, +1-212-845-4271 This e-mail address is being protected from spambots. You need JavaScript enabled to view it This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 68

Newsletter